EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence in Reproductive Medicine: Transforming Diagnosis, Treatment, and IVF Outcomes

Santosh Ramesh Achwani, Faique Tanvir Falke, C. Anchana Devi, C. Oviya, Harish Narayanan, Rajkumar Krishnan Vasanthi, Shamina S, Sovan Bagchi

Hellenic Journal of Obstetrics and Gynecology · 09.04.2026 · 25 (2) · 176-189

DOI: 10.33574/hjog.0626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hellenic Journal of Obstetrics and Gynecology, online erschienen am 09.04.2026. Verfasst von Santosh Ramesh Achwani und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial Intelligence (AI) is rapidly transforming assisted reproductive technologies (ART) by enhancing diagnostic accuracy, treatment personalization, and clinical decision-making. AI-driven tools can predict embryo viability, optimize sperm selection in real time, and tailor ovarian stimulation protocols to individual patient characteristics. Emerging applications, such as convolutional neural networks for embryo imaging and machine learning models for sperm analysis, reduce subjectivity and improve the reproducibility of outcomes. Reinforcement learning and computer vision are also advancing stimulation regimens and laboratory automation, while robotic-assisted interventions benefit from greater precision. Despite these innovations, important challenges remain. Clinical adoption is limited by heterogeneity of training datasets, algorithmic bias, and a lack of transparency in model design. Ethical concerns—including data privacy, informed consent, and equitable access and potential health risks—further complicate integration into fertility care. Moreover, financial and infrastructural barriers restrict widespread implementation, particularly in resource-limited settings. This review highlights current computational approaches, evaluates their contributions to embryo and gamete assessment, ovarian stimulation, and surgical procedures, and discusses unresolved issues of validation and regulation. Ultimately, AI holds the potential to make ART more efficient, precise, and patient-centred. Still, it’s safe and equitable integration will require interdisciplinary collaboration, robust clinical validation, and adherence to ethical and regulatory standards.

Zitieren

APA

Achwani, S. R., Falke, F. T., Devi, C. A., Oviya, C., Narayanan, H., Vasanthi, R. K., S, S., & Bagchi, S. (2026). Artificial Intelligence in Reproductive Medicine: Transforming Diagnosis, Treatment, and IVF Outcomes. Hellenic Journal of Obstetrics and Gynecology, 25(2), 176-189. https://doi.org/10.33574/hjog.0626

Vancouver

Achwani SR, Falke FT, Devi CA, Oviya C, Narayanan H, Vasanthi RK, et al. Artificial Intelligence in Reproductive Medicine: Transforming Diagnosis, Treatment, and IVF Outcomes. Hellenic Journal of Obstetrics and Gynecology. 2026;25(2):176-189. doi:10.33574/hjog.0626

BibTeX
@article{Achwani2026,
  author = {Achwani, Santosh Ramesh and Falke, Faique Tanvir and Devi, C. Anchana and Oviya, C. and Narayanan, Harish and Vasanthi, Rajkumar Krishnan and S, Shamina and Bagchi, Sovan},
  title = {Artificial Intelligence in Reproductive Medicine: Transforming Diagnosis, Treatment, and IVF Outcomes},
  journal = {Hellenic Journal of Obstetrics and Gynecology},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {176--189},
  doi = {10.33574/hjog.0626}
}
Kostenlos starten →